Most men who seek testosterone optimizationknow one thing: their T is low and they want it higher. That’s a reasonablestarting point, but the how of raising testosterone matters enormously.Different treatments work on different parts of the hormonal system, withdifferent consequences for fertility, long-term health, and treatmentsustainability.
Understanding thehypothalamic-pituitary-gonadal (HPG) axis — the system that controlstestosterone production — is the key to understanding why Luvo offers threedistinct medications and why the right choice depends on where your system isfailing.
Testosterone production is controlled by athree-level signaling cascade.
Level one is the hypothalamus. This brainstructure produces gonadotropin-releasing hormone (GnRH) in a pulsatile pattern— roughly every 60–90 minutes. The pulsatile nature of GnRH release iscritical; continuous GnRH exposure actually suppresses the pituitary ratherthan stimulating it.
Level two is the anterior pituitary gland. Inresponse to pulsatile GnRH, the pituitary releases two gonadotropins:luteinizing hormone (LH), which stimulates the Leydig cells in the testes toproduce testosterone, and follicle-stimulating hormone (FSH), which stimulatesthe Sertoli cells to support sperm production.
Level three is the testes. Leydig cellsreceive the LH signal and synthesize testosterone from cholesterol through aseries of enzymatic conversions. The testosterone enters the bloodstream andexerts its effects throughout the body. Sertoli cells, stimulated by FSH,create the environment necessary for spermatogenesis.
The system is regulated by negative feedback:testosterone (and its metabolite estradiol) signal back to the hypothalamus andpituitary, modulating GnRH, LH, and FSH output to maintain homeostasis. Whenthe system works properly, testosterone levels are maintained within afunctional range.
Low testosterone can result from failure atdifferent levels of the HPG axis, and identifying where the problem lies isessential for choosing the right treatment.
Primary hypogonadism means the testesthemselves are failing. Despite adequate LH and FSH signaling, the Leydig cellscan’t produce sufficient testosterone. In this case, LH and FSH levels are elevated(the pituitary is working harder to compensate) while testosterone remains low.Causes include testicular injury, genetic conditions like Klinefelter syndrome,and age-related Leydig cell decline.
Secondary hypogonadism means the problem isupstream — the hypothalamus or pituitary isn’t sending adequate signals. LH andFSH levels are low or inappropriately normal, and the testes aren’t beingstimulated to produce testosterone. This is the more common pattern inage-related testosterone decline, obesity-related low T, and stress-inducedhormonal suppression.
Mixed hypogonadism involves dysfunction atmultiple levels — both reduced signaling and reduced testicular response. Thisis increasingly common in older men.
Luvo’s providers use comprehensive bloodworkto identify which pattern is present, because the answer directly determinesthe optimal treatment strategy.
Each medication in Luvo’s testosterone programintervenes at a different point in the HPG axis, which is why having all threeavailable is a clinical advantage.
Testosterone medication works at the end ofthe chain, directly replacing the hormone the testes aren’t producing enoughof. It’s the most direct and potent approach — it reliably raises testosteroneregardless of where the system is failing. The trade-off is that exogenoustestosterone suppresses the upstream signaling (GnRH, LH, FSH), leading totesticular suppression.
Enclomiphene works at the top of the chain, atthe hypothalamic level. By blocking estrogen’s negative feedback, it increasesGnRH output, which increases LH and FSH, which stimulates the testes to producemore testosterone naturally. This preserves the entire axis but depends on thetestes being capable of responding to increased stimulation.
Gonadorelin works at the middle of the chain,directly stimulating the pituitary to release LH and FSH. It’s most valuable asan adjunct to TRT, replacing the GnRH signal that exogenous testosteronesuppresses and maintaining testicular function during testosterone replacement.
This three-level approach is what makes Luvo’sprogram unique. Rather than offering one solution for every patient, we matchthe intervention to the level of the HPG axis where it’s most needed. Exploreall three options: testosterone medication, Enclomiphene, and Gonadorelin.
When a telehealth clinic offers only TRT withno alternatives, they’re giving every man the same tool regardless of where hissystem is failing. A man with secondary hypogonadism (a signaling problem)might respond beautifully to Enclomiphene, preserving his fertility andmaintaining a functional HPG axis — but if TRT is the only option, he’ll getexogenous testosterone and all the suppressive effects that come with it.
Conversely, a man with primary hypogonadismwon’t respond well to Enclomiphene because his testes can’t increase productioneven with more LH stimulation. He needs testosterone replacement, ideally withGonadorelin to preserve what testicular function remains.
Luvo’s diagnostic approach identifies whichscenario applies to you, and our three-medication toolkit ensures you get thetreatment that matches your physiology — not just the treatment that’s easiestto prescribe.
Visit Luvo’s testosterone program to startwith a comprehensive hormonal evaluation.
Testosterone replacement therapy has an imageproblem. For many people, TRT conjures images of bodybuilders, steroid abuse,and health risks. The reality is far more nuanced — and far more clinical.
TRT is a legitimate, well-studied medicaltreatment for men with clinically low or suboptimal testosterone levels. Whenproperly prescribed and monitored, it restores testosterone to physiologicallevels — not supraphysiological ones. The goal isn’t to create artificiallyelevated testosterone; it’s to restore what time and biology have taken away.
Luvo’s testosterone program offers TRT as onecomponent of a comprehensive hormone optimization approach, paired withclinical monitoring and complementary medications like Enclomiphene andGonadorelin when appropriate.
Testosterone replacement therapy introducesexogenous (externally sourced) testosterone into the body, raising bloodtestosterone levels to a target range determined by your provider. Thetestosterone used in TRT is bioidentical — chemically identical to thetestosterone your body produces naturally.
Once administered, exogenous testosteroneenters the bloodstream and binds to androgen receptors throughout the body.These receptors are found in muscle tissue (stimulating protein synthesis andmuscle growth), bone cells (supporting bone density and mineralization), thebrain (influencing mood, cognition, and motivation), fat tissue (promotinglipolysis and reducing fat storage), reproductive organs (supporting libido andsexual function), and red blood cell precursors (stimulating erythropoiesis).
The effects of TRT develop over differenttimescales. Improvements in energy, mood, and libido often appear within 3–6weeks. Body composition changes — increased muscle mass and decreased body fat— typically become noticeable over 3–6 months. Bone density improvements maytake 12 months or longer to manifest.
TRT is appropriate for men with documented lowor suboptimal testosterone levels confirmed by blood work, along with symptomsconsistent with testosterone deficiency. Ideal candidates typically include menwith total testosterone consistently below 300–400 ng/dL, men with symptoms oflow T despite levels in the low-normal range of 300–500 ng/dL, men who haveruled out or addressed reversible causes such as sleep apnea, obesity, andmedication effects, and men without contraindications including untreatedprostate cancer, severe untreated sleep apnea, or uncontrolled heart failure.
TRT is generally not recommended as afirst-line treatment for younger men who wish to preserve fertility, sinceexogenous testosterone suppresses the HPG axis and can significantly reducesperm production. For these men, Luvo offers Enclomiphene and Gonadorelin asalternatives or adjuncts.
Luvo’s providers conduct thorough bloodworkand clinical evaluation before prescribing TRT, ensuring it’s the rightintervention for your specific situation.
The benefits of properly administered TRT arewell-documented across multiple domains.
Body composition improves significantly.Meta-analyses show that TRT produces an average increase in lean body mass of3–5 pounds and a decrease in fat mass of 3–4 pounds over 6–12 months, evenwithout changes to diet or exercise. When combined with resistance training andproper nutrition, the improvements are substantially greater.
Sexual function responds reliably totestosterone optimization. Libido, erectile function, and sexual satisfactionall improve in men with low baseline testosterone. TRT doesn’t replacetreatments for ED caused by vascular or neurological factors, but when low T isa contributing cause, the improvement can be dramatic.
Mood, cognition, and energy are among theearliest and most appreciated benefits. Men frequently describe feeling likethemselves again — more motivated, more mentally sharp, and more emotionallystable. Clinical studies support reductions in depressive symptoms andimprovements in verbal memory and spatial reasoning.
Bone density increases over 12–24 months,reducing fracture risk — an increasingly important concern as men age.
Metabolic health markers often improve,including insulin sensitivity, lipid profiles, and inflammatory markers. Someresearch suggests TRT may reduce the risk of metabolic syndrome and Type 2diabetes in men with low testosterone.
TRT is not risk-free, and responsibleprescribing requires ongoing monitoring. This is where Luvo’s program differssignificantly from competitors who may offer TRT with minimal follow-up.
Erythrocytosis (elevated red blood cell count)is the most common side effect of TRT, occurring because testosteronestimulates red blood cell production. If unchecked, this can increase bloodviscosity and cardiovascular risk. Luvo monitors hematocrit levels regularlyand adjusts dosing or recommends blood donation if levels rise too high.
Testicular suppression occurs becauseexogenous testosterone signals the pituitary to reduce LH and FSH production,which can cause testicular atrophy and reduced sperm production. Luvo addressesthis proactively with Gonadorelin, which maintains gonadotropin signaling andtesticular function alongside TRT.
Estrogen conversion can occur as sometestosterone is converted to estradiol by the aromatase enzyme. Symptoms ofelevated estrogen include water retention, mood changes, and gynecomastia. Luvomonitors estradiol levels and can adjust protocols accordingly.
Regular bloodwork — including total and freetestosterone, estradiol, hematocrit, PSA, and metabolic panels — is anon-negotiable part of Luvo’s TRT program. This level of monitoring is whatseparates responsible hormone optimization from reckless prescribing.
Learn more about Luvo’s testosteronemedication and the full testosterone program.
Here’s a scenario that plays out in men’shealth clinics every day: a man in his early 30s has symptoms of lowtestosterone. He’s fatigued, his libido is low, he’s gaining weight. He getsbloodwork, confirms his T is low, and starts testosterone replacement therapy.He feels great.
Two years later, he and his partner starttrying to have a baby. A semen analysis reveals his sperm count is near zero.He’s now facing months or years of recovery — and the possibility that hisfertility may never fully return to pre-TRT levels.
This scenario is entirely preventable. Theproblem isn’t that TRT is dangerous — it’s that most TRT protocols ignorefertility preservation from the start. Luvo’s testosterone program is builtdifferently, offering a range of approaches that let men optimize testosteroneand protect reproductive function simultaneously.
Understanding the mechanism is critical formaking informed treatment decisions.
Your hormonal system operates on feedbackloops. The hypothalamus produces GnRH, which tells the pituitary to produce LHand FSH. LH stimulates the testes to produce testosterone. FSH stimulates thetestes to produce sperm. When testosterone levels are sufficient, thehypothalamus reduces GnRH output, completing the feedback loop.
When you introduce exogenous testosterone,blood levels rise quickly to the target range. The hypothalamus detects thisand dramatically reduces GnRH output. The pituitary, receiving little GnRH,stops producing meaningful amounts of LH and FSH. Without FSH, the Sertoli cellsin the testes that support sperm development lose their stimulation. Spermproduction can decline by 90% or more.
This isn’t a rare side effect — it’s theexpected physiological response. It happens to virtually every man on TRT whodoesn’t take steps to prevent it.
For men whose primary concern is preservingfertility while addressing low testosterone, Enclomiphene offers an elegantsolution. By blocking estrogen feedback at the hypothalamus, Enclomiphene increasesGnRH, LH, and FSH — stimulating both testosterone and sperm productionsimultaneously.
This approach is particularly attractive formen in their 20s and 30s who are actively trying to conceive or expect to inthe near future, men with mild-to-moderate testosterone deficiency who mayrespond well to enhanced endogenous production, and men who want to try themost conservative approach first.
The limitation of Enclomiphene is that thedegree of testosterone elevation may be less than what TRT provides. Men withvery low baseline testosterone or primary testicular failure may not achievesufficient improvement with Enclomiphene alone.
Luvo’s providers evaluate each man’s hormonalprofile to determine whether Enclomiphene alone is likely to provide adequatetestosterone optimization.
For men who need the more robust testosteroneelevation that TRT provides but still want to protect fertility, thecombination of testosterone medication and Gonadorelin is Luvo’s recommendedapproach.
TRT raises testosterone levels reliably andsubstantially, delivering the full range of symptomatic benefits. Gonadorelin,administered alongside TRT, replaces the GnRH signal that exogenoustestosterone suppresses. This keeps the pituitary producing LH and FSH,maintaining testicular function and sperm production even in the presence ofexogenous testosterone.
This combination provides the best of bothworlds: optimal testosterone levels for symptom relief and quality of life,plus preserved reproductive capacity. It’s a protocol that requires moreclinical sophistication to manage, which is why it’s not commonly offered byhigh-volume telehealth competitors that prioritize simplicity overoptimization.
Some patients benefit from all threemedications working together. In this approach, TRT provides the primarytestosterone elevation. Gonadorelin maintains pituitary and testicularfunction. Enclomiphene provides additional endogenous stimulation and helpsmanage estrogen-related effects.
This triple protocol is the most comprehensiveoption in Luvo’s testosterone program and represents a level of hormonaloptimization that few telehealth platforms offer. It’s typically reserved formen who want maximum testosterone optimization, need robust fertilitypreservation, benefit from the estrogen-modulating effects of Enclomiphene, andare comfortable with a multi-medication protocol.
Your Luvo provider will recommend the approachthat best matches your hormonal profile, symptoms, and life goals — and willadjust the protocol over time as your needs evolve.
Explore Luvo’s testosterone medication,Enclomiphene, and Gonadorelin options, or visit the full testosterone programpage.
Ask most men on testosterone replacementtherapy about fertility preservation and you’ll get a blank look. Ask theirproviders, and you might get a shrug. The reality is that many TRT protocols —especially those from high-volume telehealth clinics — prescribe testosteronewithout addressing one of its most significant consequences: suppression of thebody’s own reproductive signaling.
When you take exogenous testosterone, yourpituitary gland reduces production of luteinizing hormone (LH) andfollicle-stimulating hormone (FSH). Without LH, the testes reduce their owntestosterone production. Without FSH, sperm production declines. For some men,this means testicular atrophy and near-zero sperm counts within months ofstarting TRT.
Gonadorelin is the solution to this problem,and it’s a core component of Luvo’s testosterone program. Here’s why itmatters.
Gonadorelin is a synthetic analog ofgonadotropin-releasing hormone (GnRH) — the hormone naturally produced by thehypothalamus to signal the pituitary gland. When administered in pulsatilefashion (mimicking the body’s natural release pattern), Gonadorelin stimulatesthe pituitary to produce LH and FSH.
This is significant during TRT becauseexogenous testosterone suppresses GnRH from the hypothalamus. The pituitary,receiving no GnRH signal, stops producing LH and FSH. Gonadorelin replaces thismissing signal, keeping the pituitary active and maintaining downstream gonadalfunction.
The result is that the testes continue toproduce sperm and contribute their own testosterone, even while exogenoustestosterone is being administered. Testicular volume is maintained, and theHPG axis remains functional rather than being completely suppressed.
This mechanism makes Gonadorelin fundamentallydifferent from hCG (human chorionic gonadotropin), which was historically usedfor this purpose. While hCG mimics LH directly at the testicular level,Gonadorelin works upstream at the pituitary — preserving the entire signalingcascade rather than just one step of it.
Many men starting TRT in their 30s or 40s saythey’re “done having kids” or “not planning on it.” While that may be truetoday, life circumstances change. Relationships change. Decisions that seemedpermanent at 35 look different at 42.
Beyond future fertility, there are otherreasons to maintain testicular function during TRT.
Testicular atrophy is cosmetically andpsychologically significant for many men. The reduction in testicular size thatoccurs with unsupported TRT is noticeable and can affect self-image andconfidence — ironic for a therapy meant to improve exactly those things.
Intratesticular testosterone productioncontributes to local tissue health beyond just sperm production. The testesproduce hormones and signaling molecules that support the broader reproductivesystem.
HPG axis preservation makes it easier todiscontinue TRT if you ever choose to. Without Gonadorelin, prolonged TRT candeeply suppress the HPG axis, making recovery of natural testosteroneproduction difficult and prolonged. With Gonadorelin maintaining pituitaryfunction, the transition off TRT is smoother.
Luvo’s program includes Gonadorelin as astandard consideration for men on TRT precisely because these benefits extendfar beyond just fertility.
Luvo’s testosterone program offers Gonadorelinas a key adjunct therapy for men on TRT. The typical protocol involvessubcutaneous injection administered multiple times per week, timed to providethe pulsatile stimulation the pituitary needs.
Your Luvo provider determines the appropriateGonadorelin protocol based on your specific situation, including your age,fertility goals, baseline hormonal status, and the testosterone dose you’rereceiving.
The combination of testosterone medication andGonadorelin gives you the benefits of testosterone optimization withoutsacrificing reproductive function — a combination that competitors like Hims,Willow, and Found rarely offer as an integrated protocol.
For men who want to optimize testosterone withoutexogenous testosterone at all, Gonadorelin can also be used alongsideEnclomiphene for a fully endogenous approach that stimulates the body’s ownproduction from both the pituitary and hypothalamic levels.
Learn more about Gonadorelin at Luvo, or explorethe complete testosterone program.
Is Gonadorelin the same as hCG? No.Gonadorelin is a GnRH analog that works at the pituitary level, while hCGmimics LH at the testicular level. Gonadorelin preserves the full HPG signalingcascade, which many clinicians consider a more physiological approach.Additionally, hCG has faced supply and regulatory challenges in recent years,making Gonadorelin an increasingly preferred alternative.
Does Gonadorelin have side effects? Sideeffects are generally mild. Injection-site reactions are the most common. Somemen experience mild headaches or temporary discomfort at the injection site.Serious adverse effects are rare at the doses used for fertility preservation.
Can Gonadorelin fully prevent fertility losson TRT? While no intervention provides a 100% guarantee, Gonadorelinsignificantly mitigates the suppressive effects of TRT on sperm production.Most men maintain meaningful sperm counts when Gonadorelin is used consistentlyalongside TRT.
How long do I need to take Gonadorelin?Typically, for as long as you’re on TRT and want to maintain testicularfunction and fertility potential. Your Luvo provider will guide this decisionbased on your evolving goals and clinical status.